GIRCI Auvergne Rhone-Alpes
GIRCI Auvergne Rhone-Alpes
Explore linked clinical trials.6 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Early Optimization of Ceftazidime Regimen in Critical Care | Bacterial Infections and Mycoses, Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Pseudomonas aeruginosa Infection, Pseudomonas infection, Sepsis, Shock, Systemic Inflammatory Response Syndrome, bacterial infectious disease, gram-negative bacterial infections, toxic shock syndrome | Not yet recruiting | Not applicable | 2026-09-16 | NCT07085624 | |
| Prediction of Residual Disease by Circulating DNA Detection After Potentiated Radiotherapy for Locally Advanced Head and Neck Cancer | Locally Advanced Head and Neck Carcinoma | Recruiting | Not applicable | 2026-09-11 | NCT05710679 | |
| Evaluation of Depression Screening Methods Administered by Registered Nurses in Chronic Hemodialysis Patients | depressive disorder, mood disorder, psychiatric disorder | Recruiting | Not applicable | 2026-07-23 | NCT07651436 | |
| Restrictions on Maternity Ward Visits: Current Situation, Challenges and Recommendations in the Auvergne Rhone-Alpes Region (AuRA) | Newborn Health; Post Partum Women | Not yet recruiting | Not applicable | 2026-06-17 | NCT07653646 | |
| Intrinsic Validity of Molecular Marker(s) Detection on Tissular Tumoral DNA to Predict the Efficacy of 177Lutetium-PSMA-617 (Lu-PSMA) Treatment for Castration-resistant Metastatic Prostate Cancer | Castration-resistant Metastatic Prostate Cancer; Treated by 177Lutetium-PSMA-617 (Lu-PSMA) | Recruiting | Not applicable | 2025-12-31 | NCT06600802 | |
| Assessing Shoulder Pathways Involving the Cuff | Rotator Cuff Related Shoulder Pain; Rotator Cuff Shoulder Syndrome and Allied Disorders | Not yet recruiting | Not stated | 2025-04-30 | NCT06893900 |